Metastases Stocks List

Related ETFs - A few ETFs which own one or more of the above listed Metastases stocks.

Metastases Stocks Recent News

Date Stock Title
Nov 24 AMGN Is There An Opportunity With Amgen Inc.'s (NASDAQ:AMGN) 49% Undervaluation?
Nov 22 AMGN Why Amgen (AMGN) is a Top Value Stock for the Long-Term
Nov 22 AMGN RFK Jr. Spooks Weight-Loss Stocks. Should Eli Lilly, Novo Nordisk Be Worried?
Nov 21 AMGN Eli Lilly Stock Tumbles As Kennedy Targets Weight Loss Drugs
Nov 21 NVCR Novocure secures FDA approval for add-ons to brain cancer treatment wearable
Nov 21 NVCR Novocure gets FDA approval for its HFE transducer arrays for glioblastoma treatment
Nov 21 NVCR Novocure Data at 2024 SNO Annual Meeting Highlights Product Innovation and Real-World Evidence for Tumor Treating Fields (TTFields) Therapy in Glioblastoma
Nov 21 NVCR FDA Approves Novocure’s Innovative HFE Transducer Arrays for Use With Optune Gio® for Glioblastoma
Nov 21 AMGN Analysis-Wall Street awaits Amgen weight-loss drug data expected to move shares
Nov 21 AMGN Amgen picks prolific biotech founder Chang as new top scientist
Nov 21 AMGN Eli Lilly and 2 More Drug Stocks to Buy After RFK-Inspired Drop
Nov 20 AMGN AMGEN ANNOUNCES SENIOR EXECUTIVE RESEARCH APPOINTMENT
Nov 20 AMGN SLN Stock Down Despite Cholesterol Drug Lowering Lipoprotein Levels
Nov 19 AMGN Amgen Stock Has High Implied Volatility. An Iron Condor Takes Advantage.
Nov 19 AMGN Silence Therapeutics' Zerlasiran Has Competitive Concerns: Analyst
Nov 18 AMGN Amgen Sells Off: Keep Calm And Buy The Dip
Nov 18 AMGN Is Amgen Inc. (AMGN) the Best Immunotherapy Stock to Buy Now?
Nov 18 AMGN Dow Tumbles Over 300 Points Following Economic Reports, Nvidia, Microsoft Decline: Fear & Greed Index Moves To 'Neutral' Zone
Metastases

Metastasis is a pathogenic agent's spread from an initial or primary site to a different or secondary site within the host's body; the term is typically used when referring to metastasis by a cancerous tumor. The newly pathological sites, then, are metastases (mets). It is generally distinguished from cancer invasion, which is the direct extension and penetration by cancer cells into neighboring tissues.Cancer occurs after cells are genetically altered to proliferate rapidly and indefinitely. This uncontrolled proliferation by mitosis produces a primary heterogeneic tumour. The cells which constitute the tumor eventually undergo metaplasia, followed by dysplasia then anaplasia, resulting in a malignant phenotype. This malignancy allows for invasion into the circulation, followed by invasion to a second site for tumorigenesis.
Some cancer cells known as circulating tumor cells acquire the ability to penetrate the walls of lymphatic or blood vessels, after which they are able to circulate through the bloodstream to other sites and tissues in the body. This process is known (respectively) as lymphatic or hematogenous spread. After the tumor cells come to rest at another site, they re-penetrate the vessel or walls and continue to multiply, eventually forming another clinically detectable tumor. This new tumor is known as a metastatic (or secondary) tumor. Metastasis is one of the hallmarks of cancer, distinguishing it from benign tumors. Most cancers can metastasize, although in varying degrees. Basal cell carcinoma for example rarely metastasizes.When tumor cells metastasize, the new tumor is called a secondary or metastatic tumor, and its cells are similar to those in the original or primary tumor. This means that if breast cancer metastasizes to the lungs, the secondary tumor is made up of abnormal breast cells, not of abnormal lung cells. The tumor in the lung is then called metastatic breast cancer, not lung cancer. Metastasis is a key element in cancer staging systems such as the TNM staging system, where it represents the "M". In overall stage grouping, metastasis places a cancer in Stage IV. The possibilities of curative treatment are greatly reduced, or often entirely removed when a cancer has metastasized.

Browse All Tags